Results 21 to 30 of about 5,111,387 (310)
Effect of MSCs and MSC-Derived Extracellular Vesicles on Human Blood Coagulation
Cells, 2019 Mesenchymal stem cells (MSCs) have emerged as a potent therapeutic tool for the treatment of a number of pathologies, including immune pathologies. However, unwelcome effects of MSCs on blood coagulation have been reported, motivating us to explore the ...
D. Silachev +16 more
semanticscholar +1 more source
Recurrent Venous Thromboembolism: What Is the Risk and How to Prevent It
Scientifica, 2012 Venous thromboembolism (VTE) that includes deep vein thrombosis and/or pulmonary embolism is a frequent, severe, and potentially lethal disease. After a first episode, VTE has a strong tendency to recur.
Gualtiero Palareti
doaj +1 more source
Haematologica, 2015 Standard treatment for Glanzmann thrombasthenia, a severe inherited bleeding disorder, is platelet transfusion. Recombinant factor VIIa is reported to be effective in Glanzmann thrombasthenia with platelet antibodies and/or refractoriness to platelet ...
Man-Chiu Poon +5 more
doaj +1 more source
Technology Advancements in Blood Coagulation Measurements for Point-of-Care Diagnostic Testing
Frontiers in Bioengineering and Biotechnology, 2019 In recent years, blood coagulation monitoring has become crucial to diagnosing causes of hemorrhages, developing anticoagulant drugs, assessing bleeding risk in extensive surgery procedures and dialysis, and investigating the efficacy of hemostatic ...
Mohammad Mohammadi Aria +2 more
semanticscholar +1 more source
Platelets, 2018 The purpose of this review is to explore the relationship between platelet bioenergetics and biomechanics and how this relationship affects the clinical interpretation of platelet function devices. Recent experimental and technological advances highlight
Mitchell J. George +6 more
doaj +1 more source
The International Prospective Glanzmann Thrombasthenia Registry: Pediatric Treatment and Outcomes
TH Open, 2019 Background Standard treatment for Glanzmann thrombasthenia (GT), a severe inherited bleeding disorder, is platelet transfusion. Recombinant activated factor VII (rFVIIa) is reported to be effective in GT with platelet antibodies and/or refractoriness to ...
Rainer B. Zotz +3 more
doaj +1 more source
Role of the blood coagulation cascade in hepatic fibrosis.
American Journal of Physiology - Gastrointestinal and Liver Physiology, 2018 Liver is the primary source of numerous proteins that are critical for normal function of the blood coagulation cascade. Because of this, diseases of the liver, particularly when affiliated with severe complications like cirrhosis, are associated with ...
Asmita Pant, A. Kopec, J. Luyendyk
semanticscholar +1 more source
Haematologica, 2015 Standard treatment for Glanzmann thrombasthenia is platelet transfusion. Recombinant activated factor VII has been shown to be successful in patients with Glanzmann thrombasthenia with platelet antibodies or who are refractory to platelet transfusions ...
Giovanni Di Minno +5 more
doaj +1 more source
Acta Biomaterialia, 2018 A dual functional polyurethane (PU) film that mimics aspects of blood vessel inner surfaces by combining surface texturing and nitric oxide (NO) release was fabricated through a soft lithography two-stage replication process. The fabrication of submicron
Li-Chong Xu, M. Meyerhoff, C. Siedlecki
semanticscholar +1 more source